APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kidney Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Kidney Medicine Market Outlook and Growth Opportunities 2026

23 December 2025197 pages

Choose your research edition.

Industry ResearchKidney Medicine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Kidney Medicine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Kidney Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kidney Medicine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Kidney Medicine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Kidney Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kidney Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Kidney Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Kidney Medicine market include Xiuzheng Pharmaceutical Group, Xiaolin Zhiyao, Sanofi, Novartis, Roche, Henan Lingrui Pharmaceutical, Kuihua yaoye, Pfizer and Sanjiu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Kidney Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Kidney Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Kidney Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kidney Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Kidney Medicine Segment by Company

Xiuzheng Pharmaceutical Group

Xiaolin Zhiyao

Sanofi

Novartis

Roche

Henan Lingrui Pharmaceutical

Kuihua yaoye

Pfizer

Sanjiu Pharmaceutical

Harbin Pharmaceutical Group

Amgen

Kidney Medicine Segment by Type

Tablet

Oral Liquid

Capsule

Kidney Medicine Segment by Application

Hospital

Pharmacy

Others

Kidney Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Kidney Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Kidney Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Kidney Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Kidney Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kidney Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Kidney Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Kidney Medicine industry.

Chapter 3: Detailed analysis of Kidney Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Kidney Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Kidney Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Kidney Medicine Industry Trends Table 2. Kidney Medicine Industry Drivers Table 3. Kidney Medicine Industry Opportunities and Challenges Table 4. Kidney Medicine Industry Restraints Table 5. Global Kidney Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Kidney Medicine Revenue Share by Company (2021-2026) Table 7. Global Kidney Medicine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Kidney Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Kidney Medicine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Kidney Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Kidney Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Kidney Medicine Company, Product Type & Application Table 13. Global Kidney Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Kidney Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Liquid Table 19. Significant Companies of Capsule Table 20. Global Kidney Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Kidney Medicine Sales Volume by Type (2021-2026) & (k units) Table 22. Global Kidney Medicine Sales Volume by Type (2027-2032) & (k units) Table 23. Global Kidney Medicine Sales Volume Share by Type (2021-2026) Table 24. Global Kidney Medicine Sales Volume Share by Type (2027-2032) Table 25. Global Kidney Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Kidney Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Kidney Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Kidney Medicine Sales Value Share by Type (2021-2026) Table 29. Global Kidney Medicine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Others Table 33. Global Kidney Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Kidney Medicine Sales Volume by Application (2021-2026) & (k units) Table 35. Global Kidney Medicine Sales Volume by Application (2027-2032) & (k units) Table 36. Global Kidney Medicine Sales Volume Share by Application (2021-2026) Table 37. Global Kidney Medicine Sales Volume Share by Application (2027-2032) Table 38. Global Kidney Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Kidney Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Kidney Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Kidney Medicine Sales Value Share by Application (2021-2026) Table 42. Global Kidney Medicine Sales Value Share by Application (2027-2032) Table 43. Global Kidney Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Kidney Medicine Sales by Region (2021-2026) & (k units) Table 45. Global Kidney Medicine Sales Market Share by Region (2021-2026) Table 46. Global Kidney Medicine Sales by Region (2027-2032) & (k units) Table 47. Global Kidney Medicine Sales Market Share by Region (2027-2032) Table 48. Global Kidney Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Kidney Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Kidney Medicine Sales Value Share by Region (2021-2026) Table 51. Global Kidney Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Kidney Medicine Sales Value Share by Region (2027-2032) Table 53. Global Kidney Medicine Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Kidney Medicine Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Kidney Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Kidney Medicine Sales by Country (2021-2026) & (k units) Table 58. Global Kidney Medicine Sales Market Share by Country (2021-2026) Table 59. Global Kidney Medicine Sales by Country (2027-2032) & (k units) Table 60. Global Kidney Medicine Sales Market Share by Country (2027-2032) Table 61. Global Kidney Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Kidney Medicine Sales Value Market Share by Country (2021-2026) Table 63. Global Kidney Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Kidney Medicine Sales Value Market Share by Country (2027-2032) Table 65. Xiuzheng Pharmaceutical Group Company Information Table 66. Xiuzheng Pharmaceutical Group Business Overview Table 67. Xiuzheng Pharmaceutical Group Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolio Table 69. Xiuzheng Pharmaceutical Group Recent Development Table 70. Xiaolin Zhiyao Company Information Table 71. Xiaolin Zhiyao Business Overview Table 72. Xiaolin Zhiyao Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Xiaolin Zhiyao Kidney Medicine Product Portfolio Table 74. Xiaolin Zhiyao Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sanofi Kidney Medicine Product Portfolio Table 79. Sanofi Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Novartis Kidney Medicine Product Portfolio Table 84. Novartis Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Roche Kidney Medicine Product Portfolio Table 89. Roche Recent Development Table 90. Henan Lingrui Pharmaceutical Company Information Table 91. Henan Lingrui Pharmaceutical Business Overview Table 92. Henan Lingrui Pharmaceutical Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolio Table 94. Henan Lingrui Pharmaceutical Recent Development Table 95. Kuihua yaoye Company Information Table 96. Kuihua yaoye Business Overview Table 97. Kuihua yaoye Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Kuihua yaoye Kidney Medicine Product Portfolio Table 99. Kuihua yaoye Recent Development Table 100. Pfizer Company Information Table 101. Pfizer Business Overview Table 102. Pfizer Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Pfizer Kidney Medicine Product Portfolio Table 104. Pfizer Recent Development Table 105. Sanjiu Pharmaceutical Company Information Table 106. Sanjiu Pharmaceutical Business Overview Table 107. Sanjiu Pharmaceutical Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Sanjiu Pharmaceutical Kidney Medicine Product Portfolio Table 109. Sanjiu Pharmaceutical Recent Development Table 110. Harbin Pharmaceutical Group Company Information Table 111. Harbin Pharmaceutical Group Business Overview Table 112. Harbin Pharmaceutical Group Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Harbin Pharmaceutical Group Kidney Medicine Product Portfolio Table 114. Harbin Pharmaceutical Group Recent Development Table 115. Amgen Company Information Table 116. Amgen Business Overview Table 117. Amgen Kidney Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Amgen Kidney Medicine Product Portfolio Table 119. Amgen Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Kidney Medicine Distributors List Table 123. Kidney Medicine Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Kidney Medicine Product Image Figure 2. Global Kidney Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Kidney Medicine Sales (2021-2032) & (k units) Figure 5. Global Kidney Medicine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Kidney Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Liquid Image Figure 11. Capsule Image Figure 12. Global Kidney Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Kidney Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Kidney Medicine Sales Volume Share by Type (2021-2032) Figure 15. Global Kidney Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Kidney Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Kidney Medicine Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global Kidney Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Kidney Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Kidney Medicine Sales Volume Share by Application (2021-2032) Figure 24. Global Kidney Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Kidney Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Kidney Medicine Sales Value Share by Application (2021-2032) Figure 27. Global Kidney Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Kidney Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Kidney Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Kidney Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Kidney Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Kidney Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Kidney Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Kidney Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Kidney Medicine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Kidney Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Kidney Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Kidney Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Kidney Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Kidney Medicine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Kidney Medicine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Liquid
  • Capsule
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Xiuzheng Pharmaceutical Group
  • Xiaolin Zhiyao
  • Sanofi
  • Novartis
  • Roche
  • Henan Lingrui Pharmaceutical
  • Kuihua yaoye
  • Pfizer
  • Sanjiu Pharmaceutical
  • Harbin Pharmaceutical Group
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kidney Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Kidney Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Kidney Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Kidney Medicine Market Dynamics
  1. 2.1 Kidney Medicine Industry Trends
  2. 2.2 Kidney Medicine Industry Drivers
  3. 2.3 Kidney Medicine Industry Opportunities and Challenges
  4. 2.4 Kidney Medicine Industry Restraints
3 Kidney Medicine Market by Company
  1. 3.1 Global Kidney Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Kidney Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Kidney Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Kidney Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Kidney Medicine Company Ranking (2024-2026)
  6. 3.6 Global Kidney Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Kidney Medicine Company Product Type and Application
  8. 3.8 Global Kidney Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Kidney Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Kidney Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Kidney Medicine Market by Type
  1. 4.1 Kidney Medicine Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Liquid
  4. 4.1.3 Capsule
  5. 4.2 Global Kidney Medicine Sales Volume by Type
  6. 4.2.1 Global Kidney Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Kidney Medicine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Kidney Medicine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Kidney Medicine Sales Value by Type
  10. 4.3.1 Global Kidney Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Kidney Medicine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Kidney Medicine Sales Value Share by Type (2021-2032)
5 Kidney Medicine Market by Application
  1. 5.1 Kidney Medicine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Kidney Medicine Sales Volume by Application
  6. 5.2.1 Global Kidney Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Kidney Medicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Kidney Medicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Kidney Medicine Sales Value by Application
  10. 5.3.1 Global Kidney Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Kidney Medicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Kidney Medicine Sales Value Share by Application (2021-2032)
6 Kidney Medicine Regional Sales and Value Analysis
  1. 6.1 Global Kidney Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Kidney Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Kidney Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Kidney Medicine Sales by Region (2027-2032)
  5. 6.3 Global Kidney Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Kidney Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Kidney Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Kidney Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Kidney Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Kidney Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Kidney Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Kidney Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Kidney Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Kidney Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Kidney Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Kidney Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Kidney Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Kidney Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Kidney Medicine Sales Value Share by Country, 2025 VS 2032
7 Kidney Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Kidney Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Kidney Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Kidney Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Kidney Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Kidney Medicine Sales by Country (2027-2032)
  6. 7.4 Global Kidney Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Kidney Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Kidney Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Kidney Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Kidney Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Kidney Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Kidney Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Kidney Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Kidney Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Kidney Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Kidney Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Kidney Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Kidney Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Kidney Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Kidney Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Kidney Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Kidney Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Kidney Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Kidney Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Kidney Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Kidney Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Kidney Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Kidney Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Kidney Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Kidney Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Kidney Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Kidney Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Kidney Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Kidney Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Kidney Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Kidney Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Kidney Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Kidney Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Kidney Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiuzheng Pharmaceutical Group
  2. 8.1.1 Xiuzheng Pharmaceutical Group Company Information
  3. 8.1.2 Xiuzheng Pharmaceutical Group Business Overview
  4. 8.1.3 Xiuzheng Pharmaceutical Group Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xiuzheng Pharmaceutical Group Kidney Medicine Product Portfolio
  6. 8.1.5 Xiuzheng Pharmaceutical Group Recent Developments
  7. 8.2 Xiaolin Zhiyao
  8. 8.2.1 Xiaolin Zhiyao Company Information
  9. 8.2.2 Xiaolin Zhiyao Business Overview
  10. 8.2.3 Xiaolin Zhiyao Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xiaolin Zhiyao Kidney Medicine Product Portfolio
  12. 8.2.5 Xiaolin Zhiyao Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Kidney Medicine Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Kidney Medicine Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Roche Kidney Medicine Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Henan Lingrui Pharmaceutical
  32. 8.6.1 Henan Lingrui Pharmaceutical Company Information
  33. 8.6.2 Henan Lingrui Pharmaceutical Business Overview
  34. 8.6.3 Henan Lingrui Pharmaceutical Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Henan Lingrui Pharmaceutical Kidney Medicine Product Portfolio
  36. 8.6.5 Henan Lingrui Pharmaceutical Recent Developments
  37. 8.7 Kuihua yaoye
  38. 8.7.1 Kuihua yaoye Company Information
  39. 8.7.2 Kuihua yaoye Business Overview
  40. 8.7.3 Kuihua yaoye Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kuihua yaoye Kidney Medicine Product Portfolio
  42. 8.7.5 Kuihua yaoye Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Kidney Medicine Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Sanjiu Pharmaceutical
  50. 8.9.1 Sanjiu Pharmaceutical Company Information
  51. 8.9.2 Sanjiu Pharmaceutical Business Overview
  52. 8.9.3 Sanjiu Pharmaceutical Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sanjiu Pharmaceutical Kidney Medicine Product Portfolio
  54. 8.9.5 Sanjiu Pharmaceutical Recent Developments
  55. 8.10 Harbin Pharmaceutical Group
  56. 8.10.1 Harbin Pharmaceutical Group Company Information
  57. 8.10.2 Harbin Pharmaceutical Group Business Overview
  58. 8.10.3 Harbin Pharmaceutical Group Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Harbin Pharmaceutical Group Kidney Medicine Product Portfolio
  60. 8.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 8.11 Amgen
  62. 8.11.1 Amgen Company Information
  63. 8.11.2 Amgen Business Overview
  64. 8.11.3 Amgen Kidney Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Amgen Kidney Medicine Product Portfolio
  66. 8.11.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Kidney Medicine Value Chain Analysis
  2. 9.1.1 Kidney Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Kidney Medicine Sales Mode & Process
  6. 9.2 Kidney Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Kidney Medicine Distributors
  9. 9.2.3 Kidney Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst